This inventor holds 2 USPTO granted patents. Top assignee: Daiichi Pharmaceutical Co., Ltd.. Active years: 2003-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokoyo, JP (2003)
- Tokyo, JP (2004)
Company Filing History:
Years Active: 2003-2004
Title: **Haruhiko Horino: Innovator in Anticoagulant Research**
Introduction
Haruhiko Horino, an esteemed inventor based in Tokyo, Japan, has made significant contributions to the field of medicinal chemistry, particularly in the development of novel anticoagulant agents. With a robust portfolio of two patents, he stands out in the pharmaceutical landscape.
Latest Patents
Horino's most recent patents revolve around sulfonyl derivatives, which are represented by a general formula (I). These compounds include variations where R is hydrogen, hydroxyl, nitro, and similar groups. They also explore options for R and R, as well as Q, which can be a saturated or unsaturated cyclic hydrocarbon group. Additionally, T represents carbonyl or its derivatives, while X and X may be methylidyne or nitrogen. The unique properties of these compounds exhibit potent factor Xa inhibiting activity, enabling them to serve as excellent anticoagulants. Notably, they provide speedy and satisfactory anti-thrombotic effects through oral administration while minimizing the likelihood of adverse effects.
Career Highlights
Horino is affiliated with Daiichi Pharmaceutical Co., Ltd., a prominent player in the pharmaceutical industry known for its commitment to healthcare innovations. His work has significantly advanced the development of drugs aimed at enhancing patient care through effective anticoagulation therapies.
Collaborations
Throughout his career, Horino has collaborated with notable colleagues, including Syozo Kobayashi and Satoshi Komoriya. These partnerships highlight the importance of teamwork in advancing pharmaceutical research and innovation, emphasizing the collective efforts required to bring novel therapeutics to fruition.
Conclusion
Haruhiko Horino's contributions to the field of anticoagulant research underscore his role as a key innovator in medicine. His dedication to developing effective pharmaceutical solutions continues to impact patient outcomes positively, marking him as a valuable inventor in the contemporary healthcare landscape.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile